$9.23
-0.50-5.14%
At close: Jun 11, 5:00 PM EST
$9.23
N/A
After Hours: 4:00 PM EST
Orthofix Medical Inc Stock Guidance
OFIXNASDAQ
Orthofix Medical (OFIX) last issued guidance on May 21, 2026 for fiscal year 2026. The company guided revenue in the range of $838.00M - $848.00M for the period.
Compared to prior guidance, Orthofix Medical lowered its revenue forecast from a prior range of $850.00M - $860.00M.
Orthofix Medical has issued 25 guidance updates between August 5, 2022 and May 21, 2026. During this period, the company raised its outlook 3 times and lowered it 9 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 21, 2026
Guidance Period
Full Year 2026
Revenue Guidance Range
$838.00M - $848.00M
Orthofix Medical Guidance History
Review all historical guidance issued by Orthofix Medical, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Orthofix Medical (OFIX)?
The most recent guidance for Orthofix Medical (OFIX) was reported on May 21, 2026 for the fiscal year 2026. Orthofix Medical forecasted revenue between $838.00M and $848.00M for the period.
What EPS range did Orthofix Medical (OFIX) guide for?
Orthofix Medical (OFIX) guided EPS in the range of $0.40 to $0.50 for the fiscal year 2022. The consensus analyst EPS estimate is $0.40.
What revenue range did Orthofix Medical (OFIX) guide for?
Orthofix Medical (OFIX) guided revenue in the range of $838.00M to $848.00M for the fiscal year 2026.
Did Orthofix Medical (OFIX) raise or lower guidance?
Orthofix Medical (OFIX) lowered its revenue guidance from a prior range of $850.00M - $860.00M to $838.00M - $848.00M for the fiscal year 2026.
When did Orthofix Medical (OFIX) last issue guidance?
Orthofix Medical (OFIX) last issued guidance on May 21, 2026 for the fiscal year 2026.
